The Pharma Equivalent of Climate Change?
I read an interesting article while I was in the UK last week. Before I get into the article, I want to share two standard definitions;
- Corporate Social Responsibility – everything good a company contributes to society beyond the need to deliver a short term profit and follow the law
- Sustainability – meetings today’s needs without compromising the needs of future generations.
According to an article in The Independent, Professor Peter Hawkey, chair of the UK Government’s antibiotic resistance working group, reports that our use of antibiotics today is creating resistant organisms that threaten to turn common infections into untreatable diseases . Based on the definitions above, I view this as a sustainability issue.
He goes on to say that new antibiotics are needed but few drug companies are developing them, because they are not as profitable as drugs for conditions such as heart disease or cancer. This sounds like a CSR issue to me.
Interestingly, he has termed the problem ‘the medical world’s equivalent to climate change”. Is this pharma’s equivalent of climate change? Let me know your thoughts below.